Betmiga 25mg Tab - 30's

Betmiga 25mg Tab - 30's

Category: Drug Info

Specifications
Details

Content: Mirabegron 25mg

Manufacturer: Astellas Pharma Europe B.V., Netherlands

Marketing Authorization Holder: Astellas Pharma Malaysia Sdn Bhd

Product Registration Number (MAL): MAL15015106ACRZ

Content: A prolonged-release film-coated tablet designed for oral administration
  • Indications

    Betmiga is indicated for the symptomatic treatment of

  • Urgency (sudden, strong need to urinate)

  • Increased micturition frequency (frequent urination)

  • These symptoms may occur in adult patients with overactive bladder (OAB) syndrome.

  • Urgency incontinence (involuntary leakage of urine)

  • Dosage: The recommended starting dose is 25 mg once daily.

  • Administration: Swallow the tablet whole with water; do not chew, crush, or divide.

  • With or Without Food: May be taken with or without food.

  • Consistency: Take at the same time each day to help remember.

  • Missed Dose: If more than 12 hours have passed since the missed dose, skip it and take the next dose at the usual time.


View more about Betmiga 25mg Tab - 30's on main site